[Effect of carvedilol on outcome after myocardial infarction in patients with left ventricular dysfunction: the CAPRICORN randomized trial].
Costalunga
A
A
Unità Operativa di Cardiologia, Dipartimento Cardiovascolare, Ospedali Riuniti di Bergamo.
Gavazzi
A
A
D000319:Adrenergic beta-Antagonists / Q000627:therapeutic use*; D002227:Carbazoles / Q000627:therapeutic use*; D000077261:Carvedilol; D006801:Humans; D015337:Multicenter Studies as Topic; D009203:Myocardial Infarction / Q000188:drug therapy*; D011379:Prognosis; D011412:Propanolamines / Q000627:therapeutic use*; D016032:Randomized Controlled Trials as Topic
D000319:Adrenergic beta-Antagonists; D002227:Carbazoles; D011412:Propanolamines; D000077261:Carvedilol
Effetti del carvedilolo sulla prognosi dopo infarto miocardico in pazienti con disfunzione ventricolare sinistra: lo studio CAPRICORN.